Deciding to go into therapy is a big move, one that people sometimes struggle with for a variety of reasons. But now that you’ve realized therapy would be helpful for you, how to find a therapist? It’s important to know what outcome you’re hoping for and what you feel you need help achieving. It will take a little research to determine which professionals your insurance will cover and how you’ll pay any out-of-pocket costs, but asking the right questions can help you ensure you have a qualified therapist who’s also the right fit for you. Know your options While numerous types of therapy exist, perhaps the best known is cognitive behavioral therapy (CBT), which is used to treat a number of mental health issues, from anxiety to eating disorders. It focuses on uncovering unhealthy patterns of thought and exploring how a person’s thoughts, feelings and behaviors affect each other, according to the National Alliance on Mental Illness (NAMI). “Cognitive behavioral therapy is going to be an approach to treatment that looks at or tries to understand current functioning problems and address what’s maintaining those and how might a person’s current behaviors and cognitions be contributing to those challenges,” said Lynn Bufka, a clinical psychologist in Maryland and the American Psychological Association’s associate chief for practice transformation. Another type is relational psychotherapy, often focused on couple… read on > read on >
A little about: Weekly Gravy
All Sauce from Weekly Gravy:
Regular Sleep May Be Crucial for People Living With Schizophrenia
Consistently good sleep is important for everyone, but it is particularly important for patients with schizophrenia, a new study suggests. Researchers from the University of Pittsburgh, along with collaborators in Italy, used wrist monitors to measure activity and rest in 250 people, including 150 patients with schizophrenia, in both outpatient settings and in psychiatric hospitals. The investigators found that the schizophrenia patients had erratic sleep patterns, dysregulated transitions between sleep and wake cycles, and excessively rigid daily routines that were predictive of worse symptoms. “Regulating sleep and wake cycles is important for your overall health and our findings can also be extended to people without underlying mental health conditions,” said senior study author Dr. Fabio Ferrarelli, an associate professor of psychiatry at Pitt. “Most people can benefit from better sleep hygiene and paying attention to their daily routines by incorporating activity and variety in their daily lives.” Well-established research literature suggests that people suffering from schizophrenia have trouble falling asleep and get poorer rest than people without mental health conditions. Sedatives used to manage schizophrenia symptoms can extend sleep to 15 hours per day. Getting too much sleep like this can have a negative effect on symptoms. “It’s important to be mindful of how drugs that we prescribe to patients affect their health more broadly,” Ferrarelli said in a Pitt news release. “Our study shows… read on > read on >
Supreme Court Issues Temporary Order Keeping Abortion Pill Fully Available
The Supreme Court of the United States on Friday acceded to a Biden Administration emergency application and paused parts of a recent federal ruling that had limited the availability of the abortion pill mifepristone. Justice Samuel Alito Jr. issued the interim stay, which would allow women access as usual to mifepristone up until midnight next Wednesday, the New York Times reported. Alito’s move to temporarily restore full availability is not thought to have any bearing on the Court’s final decision on the case — it merely preserves the status quo while giving the justices time to review lower court rulings. Justice Alito issued the order because he oversees the appeals court whose ruling is the focus of an appeal. He ordered the groups behind the challenge to the Food and Drug Administration’s approval of mifepristone to file their brief by Tuesday at noon, the Times said. On Wednesday, a federal appeals court partially overruled Judge Matthew Kacsmaryk’s ruling made in Texas last week, which said the U.S. Food and Drug Administration’s approval of mifepristone back in 2000 was invalid and the drug should not be used. However, the three-judge appeals court panel said mifepristone could remain available for now, but it blocked mailing the pill to patients, as well as other measures the federal government has taken recently to boost access to the medication. In… read on > read on >
Kids Born Via Egg Donors, Surrogacy Grow Up Just Fine, Study Finds
The kids, no matter how they are conceived, are all right. That is the main takeaway from a new study by British researchers that found no real differences in the psychological well-being of kids who were born via sperm/egg donation or surrogacy and those born naturally by the time they reached the age of 20. “Children born through third-party reproductive donation — egg donation, sperm donation or surrogacy — are well-adjusted and have positive relationships with their parents right up to adulthood,” said study author Susan Golombok, former director of the Centre for Family Research at the University of Cambridge. For the study, the researchers followed 65 families with children born via assisted reproduction from infancy until the child turned 20. Moms and kids were interviewed and filled out questionnaires about their relationships. Their answers were compared to those of 52 families of children conceived naturally during the same period. The bottom line? “The absence of a biological [genetic or gestational] connection between children and their parents does not interfere with the development of positive relationships between them or the psychological well-being of the child,” Golombok said. The new findings are consistent with previous assessments the researchers made at ages 1, 2, 3, 7, 10 and 14, she added. Kids aren’t all that fussed about how they were born, but it may be better to… read on > read on >
Can Smarts Help Shield Folks from Obesity? Maybe Not
A teenager’s brain power appears to have little bearing on whether they will become overweight or obese as adults. British researchers found that, on average, sharper teens weighed only slightly less in adulthood than siblings who scored lower on tests of thinking skills, according to a new study published April 13 in the journal PLOS Medicine. The difference amounted to just under a half-pound for a 6-foot-tall adult, said lead author Liam Wright, a senior research fellow in population health at University College London. “We found a very small association that in practice means that, on average, siblings with higher cognitive ability are unlikely to weigh much less than siblings with lower cognitive ability,” he said. The research refutes prior studies that have linked low cognitive scores in teens to higher risk of obesity in later life. That’s because those earlier studies looked at general populations, and didn’t take into account other powerful factors besides smarts that could influence a person’s weight, Wright said. “The problem with comparing people from the general population according to their cognitive ability and BMI is that unobserved factors may explain the association,” he said. (BMI, or body mass index, is an estimate of body fat based on height and weight.) To account for those unknown factors, Wright and his colleagues analyzed data on 12,250 siblings from more than 5,600… read on > read on >
U.S. Suicide Rates Began to Rise Again in 2021
In a disappointing finding, a new report shows that suicide rates in America are on the upswing again after a momentary, and minute, decline. According to researchers from the U.S. Centers for Disease Control and Prevention, the suicide rate increased from 10.7 people per 100,000 people in 2001 to 14.2 per 100,000 in 2018. The rate then dropped to 13.5 per 100,000 through 2020, but rose again to 14.1 per 100,000 in 2021. Why suicide rates rose, then dropped, then rose again isn’t entirely clear, said senior study author Sally Curtin, a statistician at CDC’s National Center for Health Statistics. “We’re not exactly sure what happened, because we know that many of the suicide risk factors increased, depression increased and money problems increased, we know all that,” she said. And early numbers from the first half of 2022 show that the suicide rate continues to climb, Curtin added, so the short-lived decline might just have been a blip. “Unfortunately, the suicide rate bounced back after a couple of years of decline,” she said. “If you look at the long, long picture, 20 years, it’s been almost steadily increasing.” For the study, Curtin’s team used data from the U.S. National Vital Statistics System. The researchers found that suicide rates among women increased between 2020 and 2021, but that increase was significant only for women aged 75… read on > read on >
Appeals Court Keeps Abortion Pill Available, With Restrictions
A federal appeals court on Wednesday said the abortion pill mifepristone could remain available for now. But the court’s judges added some provisions to their ruling: A block on mailing the pill to patients as well as stays on other measures the federal government has taken recently to boost access to the medication. The three-member panel partially overruled Judge Matthew Kacsmaryk’s ruling in Texas last week, which said the U.S. Food and Drug Administration’s approval of mifepristone back in 2000 was invalid. Mifepristone is typically given as the first of two drugs used during a medication abortion. The U.S. Justice Department had filed its appeal of the Texas ruling on Monday. “If allowed to take effect, the court’s order would thwart FDA’s scientific judgment and severely harm women, particularly those for whom mifepristone is a medical or practical necessity,” the appeal stated. In its preliminary ruling filed on Wednesday, the federal appeals court suggested a statute of limitations bars any legal challenge to the FDA’s approval of mifepristone. The court also seemed to consider the government’s view that removing a long-approved drug from the market would have “significant public consequences.” But it left in place parts of Kacsmaryk’s ruling that rolled back a loosening of restrictions on mifepristone by the FDA in recent years. That includes a 2016 move to allow the drug to be… read on > read on >
Juul Reaches $462 Million Settlement With Six States, D.C.
(HealthDay News) – Juul Labs on Wednesday reached a $462 million settlement with several states over the aggressive marketing of its electronic cigarettes to minors. This latest settlement includes New York, California, Colorado, the District of Columbia, Illinois, Massachusetts and New Mexico. Juul settled with West Virginia earlier this week. The company has already agreed already to pay out more than $1 billion to 47 states and territories, Juul Labs said in a statement. “The terms of the agreement, like prior settlements, provide financial resources to further combat underage use and develop cessation programs and reflect our current business practices,” Juul spokesman Austin Finan told the New York Times. The latest settlement represents a near “total resolution of the company’s historical legal challenges and securing certainty for our future,” he added. Finan noted that federal data shows that underage use of Juul products has declined 95% since 2019. State attorneys general in New York and California alleged that their investigations found that Juul executives knew their marketing was attracting teens, the Times reported. “Too many young New Yorkers are struggling to quit vaping and there is no doubt that Juul played a central role in the nationwide vaping epidemic,” New York Attorney General Letitia James said in a statement on the settlement. While the company hasn’t admitted wrongdoing, its payments to plaintiffs in earlier lawsuits… read on > read on >
New Drug May Treat Rare Diseases That Make Exposure to Sunlight Painful
It sounds like the stuff of a vampire novel, but for people with a group of rare genetic disorders, exposure to sunlight can cause excruciating pain. Now, an experimental medication is showing promise for helping them better tolerate the light of day. In an early clinical trial, researchers tested the drug for patients with either of two related conditions: erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP). Both belong to a group of eight rare genetic disorders called porphyrias. Studies estimate that EPP and XLP affect one in every 75,000 to 200,000 white people. Both conditions arise from certain genetic abnormalities that cause a chemical called protoporphyrin to build up in the blood and the lining of the blood vessels. The trouble comes when a person with EPP or XLP goes into the sun: That light activates protoporphyrin in the blood vessels, which triggers inflammation, cell damage and severe pain. Both disorders usually become apparent in childhood — which, clearly, takes a toll on kids’ quality of life, said Dr. Robert Desnick, one of the researchers on the new trial. “They call themselves shadow-jumpers, because they have to run from one shady spot to another to avoid the sun,” said Desnick, a professor of genetics and genomic sciences at the Icahn School of Medicine at Mount Sinai, in New York City. Standard sunscreen offers no protection,… read on > read on >
Statins Cut Heart Risks for Folks Living With HIV
As people with HIV live longer they’re at risk of premature heart disease. But a new study finds statin drugs can cut the risk of serious heart problems by more than one-third. The U.S. National Institutes of Health trial found the cholesterol-lowering drugs so effective, in fact, that the study was stopped early. Taking the daily statin pitavastatin calcium lowered the risk of major heart events by 35% in this patient group, according to an interim analysis of data from the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) study. “The REPRIEVE study reflects the evolution of HIV science, and progress from focusing mostly on approaches to treat and control the virus to finding ways to improve the overall health of people living with HIV,” said Dr. Hugh Auchincloss, acting director of the National Institute of Allergy and Infectious Diseases (NIAID). “These new data suggest that a common cholesterol-lowering medicine could substantially improve cardiovascular outcomes in people with HIV,” he said in a news release from the NIH and the NIAID. As people with HIV live longer thanks to decades of medical research and advances, premature heart disease and other chronic conditions have emerged as leading causes of illness and death. Statins are known to prevent heart disease in those at risk in the general population. But researchers weren’t certain before the trial if… read on > read on >